Pleiotropic effects of rosuvastatin in patients with coronary artery disease. A randomized, parallel, open-label study, rosuvastatin 10mg vs ezetimibe 10mg/rosuvastatin 2.5mg.
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000003746
- Lead Sponsor
- Department of Cardiovascular Medicine, Akita University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) acute myocardial infarction within 1 month 2) chronic and acute inflammation disease(hsCRP>10mg/L) 3) 37.0 degrees Celsius <= 4) allergy against rosuvastatin 5) allergy against ezetimibe 6) acute hepatitis, acute exacerbation of chronic hepatitis, liver cirrhosis, liver cancer, jaundice 7) chronic renal failure(Cr>=2.0mg/dL or Ccr<30mL/min/1.73m2) 8) patients treated with cyclosporine 9) pregnant 10) subjects whose doctor in charge do not agree to join the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method